italy who covid
The COVID-19 outbreak and the associated containment measures
The stringent lock-down measures imposed by the Italian government in March including production shutdowns |
Characteristics of COVID-19 patients dying in Italy Report based on
20 mars 2020 The present report describes characteristics of 3200 COVID-19 patients dying in Italy.* Geographic distribution across the 19 regions and 2 ... |
High proportion of healthcare workers with COVID-19 in Italy is a
Geneva Switzerland |
Information request_submission template
18 mars 2020 Coronavirus COVID-19 outbreak in the EU. Fundamental Rights Implications. Country: Italy. Contractor's name: Fondazione “Giacomo Brodolini”. |
AGRI Italy Platform: Information note on COVID-19 measures and
9 déc. 2020 Agriculture (the “AGRI Italy Platform”) launched on 24 January 2018 and ... mitigating the impact of the COVID-19 crisis on the Italian ... |
Working Paper Series - Covid-19 and rural landscape: the case of Italy
This study links the diffusion of covid-19 to the socio-economic and environmental features of the Italian territory. It does so by collecting and matching data |
COVID-19 RESPONSE: COMPARATIVE CASE STUDY BETWEEN
HEALTH INEQUALITIES CASE STUDIES. COVID-19 RESPONSE: COMPARATIVE CASE STUDY. BETWEEN ITALY SWEDEN. AND SOUTH KOREA. DECEMBER 2021 |
CORONAVIRUS: IMPACT ON ECONOMY
CORONAVIRUS: IMPACT ON ECONOMY. ITALY: "In recent history Italian tourism has never experienced a crisis like this. It is the darkest moment. |
Clinical trials management in Italy during the COVID-19
provides indications regarding the management of clinical trials in Italy during the COVID-19. (coronavirus disease 19) emergency valid until further |
Impacts of the COVID-19 pandemic on EU industries
8 mars 2021 1) What is the impactof COVID-19 on the EU economy and how is the ... Italy |
Italy on COVID-19: Response and Strategy - ResearchGate
PDF Coronavirus Diseases (COVID-19) in Italy was remarkably immense with more than two hundred thousand infected cases and more than thirty thousand |
Response to COVID-19: was Italy (un)prepared?
The aim of the paper is to critically review the Italian response to the COVID-19 crisis spanning from the first early acute phases of the emergency (March–May |
The effect of control measures on COVID-19 transmission in Italy
This study aims to investigate the dynamics of the disease spread in Italy and provide some suggestions on containing the epidemic Methods: We compared Italy's |
Characteristics of SARS-CoV-2 patients dying in Italy Report based
5 oct 2021 · The present report describes the characteristics of 130468 SARS-CoV-2 patients dying in Italy from the beginning of the surveillance to the 5th |
COVID-19 and primary care: A perspective from Italy - Elsevier
In this manuscript we describe the response of Italian primary health care to the COVID-19 pandemic and the management of community outpatients The first point |
Covid-19 and rural landscape: the case of Italy
This study links the diffusion of covid-19 to the socio-economic and environmental features of the Italian territory It does so by collecting and matching data |
Spread and dynamics of the COVID-19 epidemic in Italy - PNAS
As of March 25 2020 a total of 467593 cases of coronavirus disease 2019 (COVID-19) have been confirmed worldwide in 181 countries (15) In Italy a hotspot |
COVID-19 in Italy: An Overview from the First Case to Date
17 mar 2020 · The authors report an overview of how the Italian health service is facing this crisis after two months from the first internal reported cases |
COVID-19 RESPONSE: COMPARATIVE CASE STUDY BETWEEN
Figure 1 illustrates the cumulative confirmed COVID-19 cases in Italy COVID-19 restrictions to provide comparison between Italy Sweden and |
An unprecedented challenge - Dors
This report tells the story of the first phase of Italy's response to the COVID-19 virus which in many people transformed into the dreaded illness known as |
When did Italy report COVID?
First outbreakWuhan, Hubei, China Index case Rome Arrival date 31 January 2020 (3 years, 3 months, 1 week and 2 days) Confirmed cases 25,788,387 Which vaccine is approved in Italy?
Based on the Ministry's statement, it means that only the following vaccines listed below are recognised as valid proof of vaccination in Italy: Comirnaty Pfizer-BioNTech by BioNTech Manufacturing GmbH. Spikevax, formerly Moderna by Moderna Biotech Spain, SL. Vaxzvria, formerly AstraZeneca by AstraZeneca Ab.- Following the protocol, the first imported case in Spain was detected in La Gomera, in the Canary Islands, on 31 January, while the first case of locally acquired COVID-19 was confirmed on 26 February [5,6].
Italy
ITALY The COVID-19 outbreak and the associated containment measures have pushed Italy's economy into a deep contraction According to the national |
Temporal dynamics in total excess mortality and COVID-19 deaths
Methods: Data from the Italian rapid mortality surveillance system was used to quantify excess deaths during the epidemic, to estimate the mortality deficit during |
COVID-19 and haemostasis: a position paper from Italian Society on
Hospital, University of Florence, Italy The ongoing pandemic of Coronavirus disease 2019 (COVID-19) is severely challenging healthcare systems all around |
ANNEX COVID-19 TRAVEL GUIDANCE Italian Covid-related travel
12 jan 2021 · Persons entering Italy from these Countries will only be required to fill in a self- declaration form specifying, (i) the Countries they visited over the |
COVID-19 lockdown and its latency in Northern Italy - Nature
Northern Italy, the COVID‑19 most affected area, as revealed by noise variation at seismic stations The reaction to lockdown was slow and not homogeneous |
Mortality rate and gender differences in COVID-19 patients dying in
According to the Istituto Superiore di Sanità, Italian epidemiologic data show that patients af- fected from one to 3 comorbidities and over 70 years are more likely |
COVID-19 mortality among migrants living in Italy - Istituto Superiore
The proportions of natives and migrants among the COVID-19-related deaths ( 97 5 and 2 5 , respectively) were similar to the rela- tive all-cause mortality rates |